Clinical Trial Update: AZD4573 in Novel Combinations With Anti-cancer Agents in Patients With Advanced Blood Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial of AZD4573 in novel combinations with anti-cancer agents for advanced hematologic malignancies; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancies

Drugs mentioned

• AZD4573

Snippet

Sponsor: AstraZeneca | Conditions: Advanced Haematological Malignancies | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2025-02-21